small molecule

SOMA

CARISOPRODOL

Loss of exclusivityloss of exclusivity
CompanyMYLAN SPECIALTY LP

Drug detail

Brand nameSOMA
Active ingredientCARISOPRODOL
Strength250MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

SOMA patent cliff — loss of exclusivity — | CliffBio